homocysteic acid has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T; Ukai, W | 1 |
| Folbergrová, J; Haugvicová, R; Houstek, J; Jesina, P; Lisý, V | 1 |
| Miguel, TL; Pobbe, RL; Spiacci Junior, A; Zangrossi Junior, H | 1 |
| Ali, N; Cole, PD; Gulinello, M; Vijayanathan, V | 1 |
| Druga, R; Folbergrová, J; Otáhal, J | 1 |
| Folbergrová, J; Haugvicová, R; Mares, P | 2 |
| Ferrante, RJ; Kubilis, J; Lee, J; Neve, R; Ratan, RR; Ross, BD; Ryu, H; Zaman, K | 1 |
| Adalbert, R; Engelhardt, JI; Siklós, L | 1 |
| Lapin, IP; Ryzhov, IV | 1 |
1 review(s) available for homocysteic acid and Disease Models, Animal
| Article | Year |
|---|---|
[Endogenous convulsants (review)].
Topics: Amino Acids; Animals; Carbolines; Cats; Cerebral Cortex; Convulsants; Cysteic Acid; Cysteine; Disease Models, Animal; Dogs; Estrogens; Folic Acid; Homocysteine; Kynurenine; Methionine; Mice; Neurotransmitter Agents; Prostaglandins; Pyridoxal Phosphate; Quinolinic Acid; Quinolinic Acids; Rats; Seizures; Spinal Cord | 1986 |
9 other study(ies) available for homocysteic acid and Disease Models, Animal
| Article | Year |
|---|---|
Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients.
Topics: Alzheimer Disease; Animals; Antibodies; Cognition Disorders; Disease Models, Animal; Homocysteine; Mice | 2016 |
Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid.
Topics: Aldehydes; Animals; Animals, Newborn; Cerebral Cortex; Convulsants; Disease Models, Animal; Down-Regulation; Electron Transport Complex I; Energy Metabolism; Epilepsy; Excitatory Amino Acid Agonists; Free Radical Scavengers; Homocysteine; Male; Metabolic Networks and Pathways; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Rats; Rats, Wistar; Seizures; Survival Rate; Time Factors; Tyrosine | 2010 |
Dorsal raphe nucleus regulation of a panic-like defensive behavior evoked by chemical stimulation of the rat dorsal periaqueductal gray matter.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Disease Models, Animal; Escape Reaction; Homocysteine; Kainic Acid; Male; Molsidomine; Panic Disorder; Periaqueductal Gray; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Wistar; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2010 |
Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.
Topics: Animals; Cognition Disorders; Dextromethorphan; Disease Models, Animal; Excitatory Amino Acid Antagonists; Folic Acid; Glutamic Acid; Homocysteine; Humans; Injections, Spinal; Male; Memory Disorders; Methotrexate; Rats; Rats, Long-Evans; Recognition, Psychology | 2011 |
Brain superoxide anion formation in immature rats during seizures: protection by selected compounds.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Anticonvulsants; Brain; Disease Models, Animal; Homocysteine; Infusions, Intraventricular; Male; Metalloporphyrins; Proline; Rats; Rats, Wistar; Seizures; Statistics, Nonparametric; Superoxides; Time Factors | 2012 |
Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroencephalography; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Frontal Lobe; Glucose; Glycine; Hippocampus; Homocysteine; Injections, Intraventricular; Male; Phosphoserine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Seizures | 2003 |
Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons.
Topics: Animals; Apoptosis; Cell Nucleus; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; DNA; DNA Damage; DNA-Binding Proteins; Glutathione; Homocysteine; Huntington Disease; Male; Mice; Mice, Transgenic; Neurons; Nitro Compounds; Oxidants; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Response Elements; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transfection; Zinc Fingers | 2003 |
Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists.
Topics: 2-Amino-5-phosphonovalerate; Age Factors; Animals; Cerebral Cortex; Disease Models, Animal; Dizocilpine Maleate; Electroencephalography; Energy Metabolism; Epilepsy; Excitatory Amino Acid Antagonists; Glucose; Homocysteine; Injections, Intraventricular; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 2000 |
DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Calcium; Calcium Signaling; Cell Death; Disease Models, Animal; Glutamic Acid; Homeostasis; Homocysteine; Male; Microscopy, Electron; Rats; Rats, Inbred Strains | 2002 |